Neurological Surgery

Publications

Found 8 results
Author Title [ Type(Desc)] Year
Filters: Keyword is Parkinson Disease  [Clear All Filters]
Journal Article
Kelm-Nelson CA, Brauer AFL, Barth KJ, Lake JM, Sinnen MLK, Stehula FJ, Muslu C, Marongiu R, Kaplitt MG, Ciucci MR.  2018.  Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.. Brain Res. 1680:1-12.
Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ et al..  2018.  Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.. Sci Transl Med. 10(469)
Kaplitt MG.  2019.  Gene-targeting approaches for movement disorders: recent advances.. Curr Opin Neurol. 32(4):566-570.
Ebani EJ, Kaplitt MG, Wang Y, Nguyen TD, Askin G, J Chazen L.  2020.  Improved targeting of the globus pallidus interna using quantitative susceptibility mapping prior to MR-guided focused ultrasound ablation in Parkinson's disease.. Clin Imaging. 68:94-98.
During MJ, Samulski RJ, Elsworth JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH et al..  1998.  In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.. Gene Ther. 5(6):820-7.
Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A et al..  2017.  Long-term follow-up of a randomized AAV2- gene therapy trial for Parkinson's disease.. JCI Insight. 2(7):e90133.
Schweitzer JS, Song B, Herrington TM, Park T-Y, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q et al..  2020.  Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.. N Engl J Med. 382(20):1926-1932.
Krishna V, Fishman PS, Eisenberg HM, Kaplitt M, Baltuch G, Chang JWoo, Chang W-C, Fernandez RMartinez, Del Alamo M, Halpern CH et al..  2023.  Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.. N Engl J Med. 388(8):683-693.